Assertio Holdings, Inc. (ASRT): Sotuvga nisbatan narx
Assertio Holdings, Inc. (ASRT) mavjud nevrologik brendlarni optimallashtirish orqali daromad keltiradi, bu esa qisqa muddatli foydani ta'minlaydi, garchi umumiy makroiqtisodiy barqarorlikka qaramay, biznes uzoq muddatda patent risklari bilan cheklangan bo'lsa-da. Daromad baholash ushbu muvozanatni aks ettiradi, bunda parametr qiymati 1.50 ga tengdir. Narxlar barqarorligi logistika zanjiridagi uzilishlarning yo'qligi va hamkor ishlab chiqarish korxonalarining aniq quvvatdan foydalanish imkoniyatlari bilan ta'minlanadi.
Assertio Holdings, Inc. (ASRT) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Assertio Holdings, Inc.|ASRT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati assertiotx.com|ASRT - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Assertio Therapeutics|ASRT - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Assertio|Shoshilinch likvidlik koeffitsiyenti assertiotx.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ASRT - Sof foyda|Prognoz qilingan sof foyda Assertio Holdings, Inc.|ASRT - Narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati assertiotx.com|ASRT - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Assertio Therapeutics|ASRT - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Assertio|ASRT - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi assertiotx.com|ASRT - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Assertio Holdings, Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:Assertio Holdings (ASRT)
P/S koeffitsiyenti biznesning bozor qiymatini uning yillik daromadiga nisbatan belgilaydi va investorlarning sotuvlar birligi uchun to'lashga tayyor bo'lgan premiumini o'lchaydi. Assertio Holdings, Inc. (ASRT) uchun kompaniyaning P/S darajasi generik dori vositalarining kengayishi va sug'urta kompaniyalari tomonidan bosim ostida daromadlarni saqlab qolish qobiliyatining bozor bahosini aks ettiradi. Ushbu ko'rsatkichning dinamikasi dori vositalarining bozor ulushi qisqarishiga qarshi kapitalizatsiya barqarorligini tekshirish imkonini beradi. Ushbu metrikaning pasayishi nevrologiya sektoridagi risklarning qayta baholanishidan signal berishi mumkin.
Raqobatdosh kompaniyalar
Narx/daromad koeffitsiyenti biogen.com|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|Regencell Bioscience Ltd (RGC) - Sotuvga nisbatan narx|AXSM: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Corp)|XENE: P/S multiplikatori|vikingtherapeutics.com - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Supernus|Sotuvga nisbatan narx Catalyst Pharma CPRX|Narxning daromadga nisbati Denali Therapeutics Inc (DNLI)|Narxning daromadga nisbati HRMY (Harmony Corp)|P/S multiplikatori BHVN (Biohaven Ltd.)|AMLX: Kapitalizatsiya va daromad nisbati|Trevi Therapeutics, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti Praxis Precision Medicines Inc PRAX|Anavex Corp (AVXL) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati CBLL|PRTA (Prothena Biosciences) - P/S multiplikatori|ALEC - Narx/daromad multiplikatori|Narxning daromadga nisbati Annexon (ANNX)|Narx/daromad koeffitsiyenti omeros.com|Neurogene Corp - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ACIU|Voyager Therapeutics - P/S multiplikatori|Narx/daromad koeffitsiyenti neumoratx.com NMRA|Scilex (SCLX) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati TVGN|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Cognition Therapeutics Inc. (CGTX)|Kapitalizatsiyaning daromadga nisbati IKT (Inhibikase Therapeutics)|Narx/daromad koeffitsiyenti cassavasciences.com|P/S multiplikatori COYA (Coya Therapeutics)|P/S multiplikatori VistaGen Therapeutics, Inc. VTGN|OVID - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Acumen Pharmaceuticals, Inc ABOS|CervoMed Inc. (CRVO) - Narxning daromadga nisbati|Alterity Therapeutics Limited - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CLNN|PEPG (PepGen Corp) - Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati Jupiter Neurosciences (JUNS)|Relmada Corp - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ANVS (Annovis Bio, Inc.)|Grace Therapeutics Inc (GRCE) - Sotuvga nisbatan narx|AIFF: Kapitalizatsiyaning daromadga nisbati|KLTO - P/S multiplikatori|neurosense-tx.com (NRSN) - Narxning daromadga nisbati|Reviva Pharmaceuticals, Inc. - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati MetaVia Inc.|Sotuvga nisbatan narx neuraxis.com NRXS|P/S multiplikatori HSDT|P/S multiplikatori passagebio.com (PASG)|Narxning daromadga nisbati Neuphoria Therapeutics NEUP|Narx/daromad koeffitsiyenti Minerva (NERV)|ATHA - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti addextherapeutics.com ADXN|ALZN: P/S multiplikatori|Sotuvga nisbatan narx Cyclerion Therapeutics, Inc. (CYCN)|Narxning daromadga nisbati Protagenic Therapeutics Inc.|KTTA: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati ATXI|P/S multiplikatori BCLI (BrainStorm Cell Therapeutics)|Narx/daromad koeffitsiyenti Cara Therapeutics Inc. (CARA)|CHRO - Narxning daromadga nisbati|Sotuvga nisbatan narx Eliem Therapeutics|ITCI (intracellulartherapies.com) - Kapitalizatsiyaning daromadga nisbati|longboardpharma.com - Bozor kapitallashuvining daromadga nisbati|MRNS (Marinus Pharmaceuticals, Inc.) - P/S multiplikatori|NKGN: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati NeuroBo (NRBO)|SAGE - Sotuvga nisbatan narx|Narxning daromadga nisbati Synaptogenix, Inc. SNPX|trevena.com - Narxning daromadga nisbati|Vigil Neuro - P/S multiplikatori|WENA (anewmeds.com) - Kapitalizatsiya va daromad nisbati|CERE: P/S multiplikatori
